Potential antitumor agents. 31. Quantitative structure-activity relationships for the antileukemic...

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Pharmacology

Background:

• Certain bis(guanylhydrazones) exhibit structural and biological similarities to DNA minor groove-binding antileukemic bisquaternary ammonium heterocycles.
• Understanding the DNA interaction and biological activity of these compounds is crucial for developing novel anticancer agents.

Purpose of the Study:

• To investigate the DNA binding properties of L1210-active bis(guanylhydrazones).
• To correlate DNA binding affinity with inhibitory activity against L1210 DNA-dependent DNA polymerase.
• To model the mammalian toxicity of these compounds.

Main Methods:

• Fluorimetric quantitation of drug displacement of DNA-bound ethidium was used to monitor DNA binding.
• In vitro inhibition of L1210 DNA-dependent DNA polymerase was assessed to determine IC50 values.
• Regression analysis was employed to model mammalian toxicity using lipophilicity (Rm values) and IC50.

Main Results:

• Bis(guanylhydrazones) demonstrated stronger binding to poly[d(A-T)] than poly[d(G-C)] DNA, similar to bisquaternary salts.
• Drug concentrations inhibiting 50% of L1210 DNA-dependent DNA polymerase (IC50) correlated linearly with DNA binding.
• No sequence specificity was observed for DNA binding.
• Mammalian toxicity was effectively modeled by a regression equation incorporating lipophilic-hydrophilic balance (Rm values) and IC50.

Conclusions:

• L1210-active bis(guanylhydrazones) interact with DNA in a manner comparable to established antileukemic agents.
• The study establishes a relationship between DNA binding, polymerase inhibition, and toxicity for these compounds.
• The findings suggest that bis(guanylhydrazones) hold potential as antileukemic agents, with predictable toxicity profiles.